We have located links that may give you full text access.
Case Reports
Journal Article
Syringoperitoneal shunt in the treatment of syringomyelia.
Neurologia i Neurochirurgia Polska 2009 May
BACKGROUND AND PURPOSE: A variety of methods have been employed for syrinx drainage, especially for treatment of syringomyelia unrelated to Chiari 1 malformation (C1M). Research on CSF circulation revealed that perpetual syrinx increase may result from disturbances of CSF flow and transient hypertension within the spinal subarachnoid space. Thus the concept of CSF drainage out of the spinal canal has arisen. The aim of the study is to present the outcome of patients with syringomyelia treated by placement of a syringoperitoneal shunt (SPS).
MATERIAL AND METHODS: An SPS was implanted in 5 patients with syringomyelia between 2004 and 2007. The syrinx was secondary to C1M in 2 patients, post-inflammatory in another 2 and idiopathic in 1 case. Myelotomy was performed over the widest part of the syrinx, at the lowest possible level. The proximal end of the drain was introduced into the syrinx rostrally, and the distal end to the peritoneum. For outcome evaluation late clinical and radiological results of treatment were used. The follow-up ranged from 1 to 4 years.
RESULTS: Clinical improvement or stabilization of symptoms was observed in 4 patients. One patient was re-operated on due to the drain slipping out of the syrinx. Despite syrinx decrease on follow-up MR scan, further clinical deterioration led to re-exploration of the cranio-cervical junction. Follow-up MR scans revealed syrinx decrease in all but 1 patient with C1M.
CONCLUSIONS: Preliminary results suggest that SPS is a safe and efficient treatment method for patients with syringomyelia not related to structural anomalies at the cranio-vertebral junction. For treatment of syringomyelia secondary to C1M following failure of cranio-cervical decompression, another exploration of this area should be considered.
MATERIAL AND METHODS: An SPS was implanted in 5 patients with syringomyelia between 2004 and 2007. The syrinx was secondary to C1M in 2 patients, post-inflammatory in another 2 and idiopathic in 1 case. Myelotomy was performed over the widest part of the syrinx, at the lowest possible level. The proximal end of the drain was introduced into the syrinx rostrally, and the distal end to the peritoneum. For outcome evaluation late clinical and radiological results of treatment were used. The follow-up ranged from 1 to 4 years.
RESULTS: Clinical improvement or stabilization of symptoms was observed in 4 patients. One patient was re-operated on due to the drain slipping out of the syrinx. Despite syrinx decrease on follow-up MR scan, further clinical deterioration led to re-exploration of the cranio-cervical junction. Follow-up MR scans revealed syrinx decrease in all but 1 patient with C1M.
CONCLUSIONS: Preliminary results suggest that SPS is a safe and efficient treatment method for patients with syringomyelia not related to structural anomalies at the cranio-vertebral junction. For treatment of syringomyelia secondary to C1M following failure of cranio-cervical decompression, another exploration of this area should be considered.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app